1. Diabetes Mellitus (DM)
The primary distinction among diabetes mellitus types lies in the mechanism of beta-cell dysfunction.
* Type 1 DM: Characterized by the autoimmune destruction of pancreatic beta cells, leading to an absolute deficiency of insulin.
* Type 2 DM: Involves progressive insulin resistance coupled with a relative defect in insulin secretion.
* Diagnosis (Requires either two abnormal tests or one abnormal test with classic symptoms):
* Fasting Plasma Glucose (FPG) $\ge 126$ mg/dL
* HbA1c $\ge 6.5%$
* 2-hour Oral Glucose Tolerance Test (OGTT) $\ge 200$ mg/dL
* Random Plasma Glucose $\ge 200$ mg/dL, accompanied by classic symptoms such as polyuria, polydipsia, or unexplained weight loss.
* First-line Pharmacotherapy: Metformin is the initial treatment for Type 2 Diabetes Mellitus (T2DM). Subsequent additions are individualized and may include SGLT-2 inhibitors, which are particularly beneficial for patients with heart failure or chronic kidney disease (CKD), or GLP-1 receptor agonists, which are effective for weight loss and provide cardiovascular benefits for atherosclerotic cardiovascular disease (ASCVD).
2. Cerebrovascular Accident (CVA) vs. Transient Ischemic Attack (TIA)
The distinction between these conditions hinges on whether an ischemic event results in permanent neurological damage or is transient.
* Transient Ischemic Attack (TIA): Defined as a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction evident on imaging. Symptoms typically resolve within an hour, although the classic definition historically allowed resolution within 24 hours.
* Cerebrovascular Accident (CVA): Involves permanent tissue infarction (ischemic stroke) or hemorrhage (hemorrhagic stroke) leading to persistent neurological deficits.
* High-Yield Action: An immediate non-contrast head CT scan is the crucial first step to exclude a hemorrhagic stroke before initiating any thrombolytic therapy, such as intravenous alteplase, which must be administered within 4.5 hours of symptom onset for ischemic CVA.
3. Diabetic Ketoacidosis (DKA) vs. Hyperosmolar Hyperglycemic State (HHS)
Both are life-threatening diabetic emergencies, but they present with distinct clinical and biochemical profiles.
| Feature | Diabetic Ketoacidosis (DKA) | Hyperosmolar Hyperglycemic State (HHS) |
| :------------------ | :------------------------------------------------ | :---------------------------------------------------------- |
| Typical Patient | Type 1 DM (typically younger individuals) | Type 2 DM (typically older individuals) |
| Pathophysiology | Absolute insulin deficiency leading to lipolysis and ketone body production | Relative insulin deficiency preventing lipolysis, thereby allowing extreme hyperglycemia |
| Blood Glucose | Usually $250 - 600$ mg/dL | Usually $> 600$ mg/dL (often exceeding $1000$ mg/dL) |
| Arterial pH | Acidotic ($< 7.30$) | Normal ($> 7.30$) |
| Ketones / Anion Gap | Positive / Elevated | Negative (or trace) / Normal |
| Primary Treatment | Intravenous (IV) fluids, IV regular insulin, and potassium repletion | Aggressive IV fluids, IV regular insulin, and potassium repletion |
4. Hypertensive Urgency vs. Emergency
The critical differentiating factor is not merely the blood pressure (BP) measurement, but the presence of End-Organ Damage.
* Hypertensive Urgency: Characterized by a severe elevation in BP (typically $\ge 180/120$ mmHg) without acute, progressive target organ damage.
* Management: Gradual reduction of BP over 24-48 hours using oral medications to prevent cerebral hypoperfusion.
* Hypertensive Emergency: Defined by a severe elevation in BP with evidence of acute target organ damage (e.g., hypertensive encephalopathy, acute myocardial infarction, aortic dissection, acute kidney injury, or pulmonary edema).
* Management: Requires admission to an intensive care unit (ICU). Titratable intravenous antihypertensives (e.g., Labetalol, Nicardipine, Nitroprusside) are administered. The Mean Arterial Pressure (MAP) should be reduced by 10-20% within the first hour, with exceptions for aortic dissection (where rapid lowering to systolic BP $< 120$ mmHg is required) or acute ischemic stroke (where permissive hypertension is allowed).
5. Electrolyte Imbalances (High-Yield Focus)
* Sodium (Na+): Disorders of sodium primarily reflect disturbances in water balance. Hyponatremia requires evaluation of volume status (hypervolemic, euvolemic, hypovolemic) and must be corrected slowly to avoid Osmotic Demyelination Syndrome. Hypernatremia also necessitates slow correction to prevent cerebral edema.
* Potassium (K+): An electrocardiogram (ECG) should always be performed.
* Hyperkalemia: ECG manifestations include peaked T waves and widened QRS complexes. Cardiac membrane stabilization with IV Calcium Gluconate is the immediate priority, followed by shifting potassium intracellularly (using insulin and glucose, or albuterol), and then promoting elimination (via loop diuretics, gastrointestinal binders, or dialysis).
* Hypokalemia: ECG findings may include U waves and flattened T waves. Concomitant magnesium replacement is crucial, as magnesium deficiency can impede potassium correction.
* Calcium (Ca2+):
* Hypercalcemia: Clinical presentation often includes "stones (kidney stones), bones (bone pain), abdominal groans (abdominal pain), and psychiatric overtones." Treatment involves aggressive intravenous fluids and bisphosphonates.
* Hypocalcemia: May manifest with Chvostek's sign (facial nerve twitch upon tapping) and Trousseau's sign (carpal spasm induced by blood pressure cuff inflation).
6. Sepsis
* Definition: A life-threatening organ dysfunction resulting from a dysregulated host response to infection, identified by an acute change in the Sequential Organ Failure Assessment (SOFA) score of $\ge 2$.
* Septic Shock: Defined as sepsis with persisting hypotension requiring vasopressors to maintain a Mean Arterial Pressure (MAP) $\ge 65$ mmHg, and a serum lactate level $> 2$ mmol/L despite adequate volume resuscitation.
* The 1-Hour Bundle:
1. Measure lactate level.
2. Obtain blood cultures prior to the administration of antibiotics.
3. Administer broad-spectrum antibiotics.
4. Initiate rapid administration of $30$ mL/kg crystalloid for hypotension or a lactate level $\ge 4$ mmol/L.
5. Apply vasopressors if hypotension persists during or after fluid resuscitation.
7. Tachy-Bradycardia
* Tachycardia (Heart Rate $> 100$ bpm): Assess patient stability.
* Unstable (characterized by hypotension, altered mental status, or ischemic chest pain): Requires immediate synchronized cardioversion (or defibrillation for pulseless ventricular tachycardia/ventricular fibrillation).
* Stable: Differentiated by QRS width. Narrow-complex tachycardias (e.g., supraventricular tachycardia, atrial fibrillation) are managed with vagal maneuvers, adenosine, or rate-control medications. Wide-complex tachycardias (e.g., ventricular tachycardia) necessitate antiarrhythmics like Amiodarone.
* Bradycardia (Heart Rate $< 60$ bpm): If symptomatic (e.g., fatigue, syncope, hypotension), the first-line pharmacotherapy is Atropine. If Atropine is ineffective, transcutaneous pacing or an infusion of dopamine/epinephrine should be initiated.
8. Anemia
Anemia is efficiently classified by Mean Corpuscular Volume (MCV):
* Microcytic (MCV $< 80$ fL): Causes include iron deficiency (characterized by low ferritin and high Total Iron-Binding Capacity [TIBC]), thalassemia, lead poisoning, and sideroblastic anemia.
* Normocytic (MCV $80-100$ fL): Causes include acute blood loss, hemolytic anemias, and anemia of chronic disease (with normal to high ferritin and low TIBC).
* Macrocytic (MCV $> 100$ fL): Megaloblastic causes include vitamin B12 deficiency (which may present with neurological symptoms) and folate deficiency (typically without neurological symptoms). Non-megaloblastic causes include alcohol abuse and liver disease.
9. Myocardial Infarction (MI) / Chest Pain
Evaluation of chest pain requires the exclusion of life-threatening causes, such as Acute Coronary Syndrome (ACS), Aortic Dissection, Pulmonary Embolism, and Tension Pneumothorax.
* STEMI (ST-Elevation Myocardial Infarction): Indicated by ST-segment elevation on the ECG or a new Left Bundle Branch Block (LBBB). Signifies total occlusion of a coronary artery. Requires emergent reperfusion therapy (percutaneous coronary intervention [PCI] within 90 minutes or fibrinolytics within 120 minutes).
* NSTEMI (Non-ST-Elevation Myocardial Infarction) / Unstable Angina: Characterized by ST depressions or T-wave inversions on the ECG. Differentiated by cardiac biomarkers: Troponins are elevated in NSTEMI but normal in Unstable Angina.
* Initial Medical Management: Involves "MONA-B" (Morphine - to be used cautiously; Oxygen - only if saturation is $< 90%$; Nitroglycerin; Aspirin; Beta-blockers) plus a P2Y12 inhibitor (e.g., Clopidogrel) and anticoagulation (e.g., Heparin).
10. COPD vs. Asthma
Both are obstructive lung diseases, yet they differ in their reversibility and underlying pathophysiology.
| Feature | Asthma | COPD |
| :-------------- | :------------------------------------------------ | :---------------------------------------------------------- |
| Onset | Typically during childhood or young adulthood | Usually after 40 years of age |
| Etiology | Airway inflammation (often allergic or eosinophilic) | Exposure to tobacco smoke, Alpha-1 antitrypsin deficiency |
| Reversibility | Reversible (Forced Expiratory Volume in 1 second [FEV1] improves $\ge 12%$ after bronchodilator administration) | Irreversible or only partially reversible obstruction |
| Primary Therapy | Inhaled Corticosteroids (ICS) complemented by as-needed bronchodilators | Long-Acting Bronchodilators (Long-Acting Muscarinic Antagonists [LAMA]/Long-Acting Beta-Agonists [LABA]). ICS are reserved for severe cases. |
11. Pancreatitis / Cholecystitis / Appendicitis
These constitute the classic triad of acute abdominal pain conditions.
* Acute Pancreatitis: Characterized by severe, sudden epigastric pain radiating to the back, often relieved by leaning forward. Elevated serum lipase (which is more specific than amylase) is diagnostic. The most common causes are gallstones and alcohol consumption. Management is primarily supportive: aggressive intravenous hydration, nil per os (NPO) for bowel rest, and pain control.
* Acute Cholecystitis: Presents with right upper quadrant (RUQ) pain, frequently occurring post-prandially (especially after fatty meals), accompanied by a positive Murphy's sign (inspiratory arrest upon palpation). Ultrasound typically reveals gallbladder wall thickening and pericholecystic fluid. Management includes NPO, intravenous antibiotics, and cholecystectomy.
* Acute Appendicitis: Initial periumbilical pain that subsequently migrates to the right lower quadrant (McBurney's point). Associated symptoms include anorexia, nausea, and fever. Management involves appendectomy.
12. Heart Failure
* HFrEF (Heart Failure with Reduced Ejection Fraction): Represents systolic dysfunction, characterized by an Ejection Fraction (EF) $\le 40%$. The heart muscle is weak and dilated. Treatment relies on guideline-directed medical therapy (GDMT) proven to reduce mortality, including beta-blockers, ACE inhibitors/ARBs/ARNIs, Mineralocorticoid Receptor Antagonists (e.g., Spironolactone), and SGLT-2 inhibitors.
* HFpEF (Heart Failure with Preserved Ejection Fraction): Involves diastolic dysfunction, with an EF $\ge 50%$. The heart muscle is stiff and hypertrophied, impairing its ability to relax and fill properly. Management focuses on blood pressure control, managing volume overload with diuretics, and treating comorbidities.
* Acute Decompensated Heart Failure: Patients present with respiratory distress and volume overload. Treatment involves "LMNOP" (Lasix/Loop diuretics, Morphine, Nitrates, Oxygen, Positioning).
13. Pyelonephritis
* Pyelonephritis is an upper urinary tract infection involving the renal parenchyma.
* Presentation: The classic triad includes fever, flank pain, and costovertebral angle (CVA) tenderness. It is often accompanied by lower urinary tract infection symptoms (dysuria, frequency) and may include nausea or vomiting.
* Diagnosis: Urinalysis reveals pyuria, positive leukocyte esterase, nitrites, and the pathognomonic finding of White Blood Cell (WBC) casts, which differentiates pyelonephritis from cystitis.
* Management: Outpatient management with oral fluoroquinolones (e.g., Ciprofloxacin) is appropriate for stable patients tolerating oral intake. Inpatient management with intravenous Ceftriaxone is indicated for complicated cases, pregnant patients, or those unable to tolerate oral intake.